BIO vs BV · rev $2.58B vs P/E 421, $1.18B cap
BIO (BIO) versus BrightView Holdings (BV) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
BrightView Holdings (BV) is a specialty business services company listed on NYSE.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
BV does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. BV currently screens at market cap $1.18B and trailing P/E 421.0.
Not investment advice. Open the BIO and BV stock pages for the full models.
Not investment advice.